# High Dose BAYA1040\_Nifedipine: a Dose-comparative Study

Study · id `cardio:ct-nct01287260` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01287260](<https://clinicaltrials.gov/study/NCT01287260>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01287260

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 352 participants.

## Technical summary

Registry record NCT01287260. Randomized; triple masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 352 participants (enrolled count; ClinicalTrials.gov record NCT01287260, source copy `cardio:ctgov-nct01287260-2014-01-29`, retrieved 2026-10-26)
- Start date: 2011-01 (registry gives no type) (ClinicalTrials.gov record NCT01287260, source copy `cardio:ctgov-nct01287260-2014-01-29`, retrieved 2026-10-26)
- Primary completion: 2011-08 (actual) (ClinicalTrials.gov record NCT01287260, source copy `cardio:ctgov-nct01287260-2014-01-29`, retrieved 2026-10-26)
- Completion: 2011-08 (actual) (ClinicalTrials.gov record NCT01287260, source copy `cardio:ctgov-nct01287260-2014-01-29`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01287260, source copy `cardio:ctgov-nct01287260-2014-01-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01287260-2014-01-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: High Dose BAYA1040\_Nifedipine: a Dose-comparative Study
- Condition: Hypertension
- Intervention (Drug): Nifedipine (Adalat, BAYA1040)
- Intervention (Drug): Nifedipine (Adalat, BAYA1040)
- Lead sponsor: Bayer
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Nifedipine (`cardio:nifedipine`)
- Registry intervention is a member of this class by a sourced record link: Calcium channel blockers (`cardio:calcium-channel-blockers`)
- Registry lists this organization as the lead sponsor: Bayer (`cardio:bayer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study (`cardio:pubmed-23945965`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d768485bce2499a7b4db6e872f2b1d0aa60570f655efd716ded3d19ef5596108
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
